Article Text

PDF
Peripartum cardiomyopathy: diagnosis and management
  1. Alice M Jackson1,
  2. Jonathan R Dalzell2,
  3. Niki L Walker2,
  4. Caroline J Coats2,
  5. Pardeep S Jhund1,
  6. Mark C Petrie1
  1. 1Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
  2. 2Golden Jubilee National Hospital, Clydebank, UK
  1. Correspondence to Professor Mark C Petrie, nstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK; mark.petrie{at}glasgow.ac.uk

Statistics from Altmetric.com

Learning objectives

  • Understand the pathways thought to be involved in the pathogenesis of PPCM

  • Become familiar with outcomes (recovery and mortality) in PPCM

  • Consider the therapeutic strategies in PPCM

Introduction

In 2010, the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy (PPCM) defined PPCM as ‘an idiopathic cardiomyopathy presenting with heart failure secondary to left ventricular (LV) systolic dysfunction towards the end of pregnancy or in the months following delivery, where no other cause of heart failure is found. It is a diagnosis of exclusion’1 (figure 1). It is important to appreciate that not all heart failure during pregnancy is due to PPCM. Other cardiovascular conditions can present during pregnancy; for example, pre-existing cardiomyopathies or previously undiagnosed congenital or valvular heart disease.

Figure 1

European Society of Cardiology PPCM Working Group definition of peripartum cardiomyopathy.

How common is PPCM?

The incidence of PPCM varies between countries and between races within countries. In Africa, among predominantly black populations, the incidence is around 1 in 1000 live births.2 There are a few countries where PPCM appears to be much more common. For example, in Nigeria and Haiti, an incidence of 1 in 100 and 1 in 300 pregnancies respectively has been reported.3 4 In the USA, the incidence in predominantly white populations is between 1 in 1000 and 1 in 4000, but in African-American populations it is between 1 in 1000 and 1 in 2000.5–7 The incidence in Europe and Australasia is not well studied. The incidence does appear to be increasing—possibly due to increased awareness and diagnosis.8

It is striking that PPCM is often only recognised when patients are very sick with severe myocardial dysfunction. It seems likely that less severe forms of PPCM go undiagnosed, with symptoms being ascribed to the stresses around the arrival of a new child …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.